Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Will The Pharmacogenetic Testing Market Valuation Change Between Now And 2029?

The pharmacogenetic testing market has seen substantial growth recently. It is set to expand from $12.37 billion in 2024 to $14.33 billion in 2025, marking a compound annual growth rate (CAGR) of 15.8%. The historical growth could be credited to escalating drug effectiveness, rising acceptance of individualized care, an expanding need for accurate diagnosis, an increased emphasis on pharmacogenetic testing, and growing medical costs.

Forecasts suggest a swift expansion of the pharmacogenetic testing market in the coming years. The predicted growth is valued at $25.62 billion in 2029 with a compound annual growth rate (CAGR) of 15.6%. The driving factors for this projected growth in upcoming years include enhanced research in biotechnology and health sector, increased healthcare spending, heightened instances of chronic illnesses, improved reach, growth of telemedicine, and digital health. The key trends in this period will likely encompass pharmacogenetic testing, innovation in genomic technologies, technological progression, strides in companion diagnostics, and pioneering diagnostic examinations.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp

Which Key Factors Are Fueling Growth In The Pharmacogenetic Testing Market?

The growing need for individualized medical treatments is anticipated to boost the expansion of the pharmacogenetic testing market. Personalized medicine, also referred to as precision medicine, designs healthcare strategies and applications based on an individual’s unique traits. The rise in personalized medicine can be attributed to several elements, including enhanced treatment results, an emphasis on early detection and prevention, and its cost-effectiveness. Pharmacogenetic testing plays a crucial role in personalized medicine by investigating a person’s genetic profile to determine how they’ll react to certain drugs. This allows healthcare professionals to customize treatments around genetic variables, maximizing drug efficiency and reducing negative side effects. For instance, in February 2024, the Personalized Medicine Coalition, an American non-profit group, reported that the FDA approved 16 unique personalized therapies for rare disease patients in 2023, which is a considerable increase from six in 2022. Consequently, the ascending demand for personalized medicine is fueling the growth of the pharmacogenetic testing market.

How Is The Global Pharmacogenetic Testing Market Broken Down By Segment?

The pharmacogenetic testing market covered in this report is segmented –

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Subsegments:

1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing

2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing

3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing

4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

Which Trends Are Likely To Redefine Growth Paths In The Pharmacogenetic Testing Market?

Leading corporations in the pharmacogenetics testing market sphere are innovating and introducing sophisticated pharmacogenomics testing services like prescription-based pharmacogenetic testing, with the intent to strengthen their market position. These genetic tests, specifically requested by healthcare providers, are utilized to examine a patient’s genetic framework prior to recommending medications. In light of this, in May 2023, an American healthcare firm called UCSF initiated its own pharmacogenomics testing service to boost accuracy in medicinal treatments. Designed to assist healthcare providers in customizing drug therapies according to a person’s genetic constitution, UCSF’s pharmacogenomics testing service aims to enhance the effectiveness of medications, reduce unwanted side effects, and foster personalized medical treatment strategies.

Which Firms Are Making The Biggest Impact In The Pharmacogenetic Testing Market?

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Pharmacogenetic Testing Market?

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=19139&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model